Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ISONIAZID Cause Neuropathy peripheral? 132 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Neuropathy peripheral have been filed in association with ISONIAZID (Isoniazid). This represents 1.7% of all adverse event reports for ISONIAZID.

132
Reports of Neuropathy peripheral with ISONIAZID
1.7%
of all ISONIAZID reports
12
Deaths
37
Hospitalizations

How Dangerous Is Neuropathy peripheral From ISONIAZID?

Of the 132 reports, 12 (9.1%) resulted in death, 37 (28.0%) required hospitalization, and 5 (3.8%) were considered life-threatening.

Is Neuropathy peripheral Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ISONIAZID. However, 132 reports have been filed with the FAERS database.

What Other Side Effects Does ISONIAZID Cause?

Drug-induced liver injury (766) Drug ineffective (607) Drug reaction with eosinophilia and systemic symptoms (550) Pyrexia (517) Nausea (488) Paradoxical drug reaction (433) Off label use (406) Drug resistance (367) Hepatotoxicity (349) Headache (324)

What Other Drugs Cause Neuropathy peripheral?

LENALIDOMIDE (10,215) BORTEZOMIB (4,067) OXALIPLATIN (3,662) DEXAMETHASONE (3,543) PACLITAXEL (3,508) LEVOFLOXACIN (2,619) CIPROFLOXACIN (2,607) FLUOROURACIL (2,605) CYCLOPHOSPHAMIDE (2,565) POMALIDOMIDE (2,382)

Which ISONIAZID Alternatives Have Lower Neuropathy peripheral Risk?

ISONIAZID vs ISONIAZID\PYRAZINAMIDE\RIFAMPIN ISONIAZID vs ISONIAZID\PYRIDOXINE\SULFAMETHOXAZOLE\TRIMETHOPRIM ISONIAZID vs ISONIAZID\RIFAMPIN ISONIAZID vs ISOPROPANOLAMINE ISONIAZID vs ISOPROPYL ALCOHOL

Related Pages

ISONIAZID Full Profile All Neuropathy peripheral Reports All Drugs Causing Neuropathy peripheral ISONIAZID Demographics